Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Recognize when index signals hint at a trend reversal and how to adjust exposure accordingly. This guidance helps protect gains and minimize losses.
24,330 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Three AI-powered models weigh two extreme BTC futures for 2026: a downturn to $30,000 or a rally to $100,000. The art...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A solid one-day move in Venture Global stock rose today as analysts lifted price targets and LNG demand expectations ...
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Space companies can soar one day and stumble the next. This article breaks down why spacex (spcx) stock plunged, what...
Amazon’s latest stake in a hot quantum stock signals a new level of tech crossover between cloud behemoths and fronti...
Major banks reduced price targets on Salesforce ahead of its Q4 earnings, sparking a broader debate about growth pros...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
Two Wall Street giants raised price targets on Super Micro Computer after a solid Q3 2026 performance, but neither mo...